Current guidelines for the treatment of patients with rheumatic fever

Drugs

Volumn 57, Issue 4, 1999, Pages 545-555

  Thatai, Deepak ^a   Turi, Zoltan G ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; BENZATHINE PENICILLIN; CEPHALOSPORIN; CLINDAMYCIN; CORTICOSTEROID; DIGOXIN; DIURETIC AGENT; ERYTHROMYCIN ESTOLATE; ERYTHROMYCIN ETHYLSUCCINATE; HALOPERIDOL; IMMUNOGLOBULIN; MEPREDNISONE; PENICILLIN G; PENICILLIN V; PREDNISONE; SALICYLIC ACID DERIVATIVE; SEDATIVE AGENT; STREPTOCOCCUS VACCINE; SULFADIAZINE; SULFONAMIDE; VASODILATOR AGENT;

ANTIBIOTIC RESISTANCE; ANTIGENICITY; BED REST; CARDITIS; CHOREA MINOR; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; ECHOCARDIOGRAPHY; ERYTHEMA; HEART BLOCK; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NAUSEA; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PENICILLIN ALLERGY; PHARYNGITIS; POLYARTHRITIS; PROGNOSIS; PUBLIC HEALTH; REVIEW; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; STREPTOCOCCUS INFECTION; SUBCUTANEOUS NODULE; VALVULAR HEART DISEASE; VOMITING;

HUMANS; PRACTICE GUIDELINES; RHEUMATIC FEVER;

EID: 0032891090     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199957040-00007     Document Type: Review

References (93)

1. 1. Kaplan MH. Immunologic relationship of streptococcal and tissue antigens: properties of an antigen in certain strains of group A streptococci exhibiting an immunologic crossreaction with human heart tissue. J Immunol 1963; 90: 595-606
2. 2. Siecel AC, Johnson EE, Stollerman GH. Controlled studies of streptococcal pharyngitis in a pediatric population: factors related to the attack of rheumatic fever. N Engl J Med 1961; 265: 559-65
3. 3. Weidebach W, Goldberg AC, Chiarella JM, et al. HLA class II antigens in rheumatic fever: analysis of the DR locus by restriction fragment-length polymorphism and oligotyping. Hum Immunol 1994; 40: 253-8
4. 4. Yoshinoya S, Pope RM. Detection of immune complexes in acute rheumatic fever and their relationship to HLA-B5. J Clin Invest 1980; 65: 136-45
5. 5. Disciascio G, Taranta A. Rheumatic fever in children. Am Heart J 1980; 99: 635-58
6. 6. Pattarroyo ME, Winchester RJ, Vejerano A, et al. Association of a B-cell alloantigen with susceptibility to rheumatic fever. Nature 1979; 278: 173-4
7. 7. Williams RC, Raizada V, Prakash K, et al. Studies of streptococcal membrane antigen-binding cells in acute rheumatic fever. J Lab Clin Med 1985; 105: 531-6
8. 8. Pope RM. Rheumatic fever in the 1980s. Bull Rheum Dis 1989; 38: 1-8
9. 9. Rose AG. Etiology of acquired valvular heart disease in adults: a survey of 18,132 autopsies and 100 consecutive valve replacement operations. Arch Pathol Lab Med 1986; 110: 385-8
10. 10. Gordis L. The virtual disappearance of rheumatic fever in the United States. Circulation 1985; 72: 1155-62
11. 11. World Health Organization. Community control of rheumatic heart disease in developing countries: a major public health problem. WHO Chronicle 1980; 34 (9): 336-46
12. 12. Rheumatic fever and rheumatic heart disease. Report of the World health Organization study group. WHO Tech Rep Ser 1988; 764: 1-62
13. 13. Agarwal BL. Rheumatic heart disease unabated in developing countries. Lancet 1981; 2 (8252): 910-1
14. 14. Veasy LG, Wiedmeir SE, Orsmond GS, et al. Resurgence of acute rheumatic fever in the intermountain areas of the United States. N Engl J Med 1987; 316: 421-7
15. 15. Hosier DM, Craenen JM, Teske DW, et al. Resurgence of acute rheumatic fever. Am J Dis Child 1987; 141: 730-3
16. 16. Congeni B, Riggo C, Congeni J, et al. Outbreak of acute rheumatic fever in north-east Ohio. J Pediatr 1987; 111: 176-9
17. 17. Wald ER, Dashefsky B, Feidt C, et al. Acute rheumatic fever in western Pennsylvania and the tri-state area. Pediatrics 1987; 80: 371-4
18. 18. Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med 1991; 325: 783-93
19. 19. Wald ER. Acute rheumatic fever. Curr Probl Pediatr 1993; 23: 264-70
20. 20. Holmer C, Shulman ST. Clinical aspects of acute rheumatic fever. J Rheumatol 1991; 18 Suppl.: 2-13
21. 21. Stollerman GH. The nature of rheumatogenic streptococci. Mt Sinai J Med 1996; 653: 144-57
22. 22. Jones TD. Diagnosis of rheumatic fever. JAMA 1944; 126: 481-4
23. 23. Kiss MHB. Articular involvement in rheumatic fever. Rev Soc Cardiol Estado de Sao Paulo 1993; 3: 26-31
24. 24. Taranta A. Rheumatic fever: clinical aspects. In: Hollander JL, editor. Arthritis and allied conditions. 7th ed. Philadelphia (PA): Lea & Febiger, 1966: 694
25. 25. Barnert AL, Terry EE, Persellin RN. Acute rheumatic fever in adults. JAMA 1975; 232: 925-8
26. 26. Carmo HF, Vilela RG, Alvarenga SL, et al. Rheumatic fever in Goiania, Brazil. Rev Bras Reumatol 1994; 34: 61-4
27. 27. da Silva NA, Pereira BA. Acute rheumatic fever: still a challenge. Rheum Dis Clin North Am 1997; 23: 545-68
28. 28. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease in the Young of the American Heart Association. Guidelines for the diagnosis of rheumatic fever: Jones criteria, 1992 update [correction. Published erratum appears in JAMA 1993; 269: 476]. JAMA 1992; 268: 2069-73
29. 29. Dajani AS, Ayoub E, Bierman FZ, et al. Guidelines for the diagnosis of rheumatic fever: Jones criteria. Updated 1992. Circulation 1993; 87: 302-7
30. 30. Amigo MC, Martinez-Lavin M, Reyes PA. Acute rheumatic fever. Rheum Dis Clin North Am 1993; 19: 333-50
31. 31. Morales E, Pineda C, Martinez-Lavin M. Takayasu's arteritis in children. J Rheumatol 1991; 18: 1081-4
32. 32. Denny FW. T Duckett Jones and rheumatic fever in 1986. Circulation 1987; 76: 963-70
33. 33. Dajani A, Taubert K, Ferrieri P, et al. Treatment of acute streptococcal pharyngitis and prevention for rheumatic fever: a statement for health professionals. Pediatrics 1995; 96: 758-64
34. 34. Bisno AL. Rheumatic fever. In: Kelly WN, Harris Jr ED, Ruddy S, et al., editors. Texthook of rheumatology. 4th ed. Philadelphia (PA): W.B. Saunders, 1993: 1209
35. 35. Pinals RS. Polyarthritis and fever. N Engl J Med 1994; 330: 769-74
36. 36. Denny FW. A 45-year perspective on the streptococcus and rheumatic fever: the Edward H. Kass lecture in infectious disease history. Clin Infect Dis 1994; 19: 1110-22
37. 37. Chan AW, Webb G, Vellend H, et al. Delayed diagnosis of acute rheumatic fever in adults: a forgotten cause of febrile poly-arthritis. J Rheumatol 1996; 23: 1999-2001
38. 38. Vasan RS, Shrivastava S, Vijayakumar MD, et al. Echocardiographic evaluation of patients with acute rheumatic fever and rheumatic carditis. Circulation 1996; 94: 73-82
39. 39. Wilson NJ, Neutze JM. Editorial: echocardiographic diagnosis subclinical carditis in acute rheumatic fever. Int J Cardiol 1995; 50: 1-6
40. 40. Gibofsky A, Zabriskie JB. Rheumatic fever: etiology, diagnosis, and treatment. In: Koopman WJ, editors. Arthritis and allied conditions. 13th ed. Baltimore (MD): Williams & Wilkins, 1997: 1581-94
41. 41. Veasy LG, Tani LY, Hill HR. Persistence of acute rheumatic fever in the intermountain area of United States. J Pediatr 1994; 124(1): 9-16
42. 42. Stollerman GH. Rheumatic fever. Lancet 1997; 349: 935-42
43. 43. Bisno AL. Rheumatic fever. In: Kelly WN, Harris Jr ED, Ruddy S, et al., editors. Textbook of rheumatology. 5th ed. Philadelphia (PA): W.B. Saunders, 1997: 1225-40
44. 44. Tompkins DG, Boxerbaum B, Liebman J. Long term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin. Circulation 1972; 45: 543-51
45. 45. Thomas GT. Five year follow-up on patients with rheumatic fever treated by bed rest, steroids or salicylates. BMJ 1961; 1: 1635-9
46. 46. Loeffler AM, Neches WH, Ortenzo M, et al. Identification of cases of acute rheumatic fever managed on an outpatient basis. Pediatr Infect Dis J 1995; 14: 975-8
47. 47. Taranta A, Markowitz M. Rheumatic fever. 2nd ed. London: Kluwer Academic Publishing, 1989
48. 48. Vaisman S, Guash J, Vignau A, et al. The failure of penicillin to alter acute rheumatic vasculitis. JAMA 1965; 194 (12): 1284-6
49. 49. Mortimer EA, Vaisman S, Vigneau A, et al. The effect of penicillin on acute rheumatic fever and valvular heart disease. N Engl J Med 1959; 260: 101-12
50. 50. Gibofsky A, McCarty M, Veasy G, et al. 'A rose by any other name...' [editorial]. J Rheumatol 1995; 22: 379-81
51. 51. Azevedo ECL. Febre reumatica. In: Oliveira SKF, Azevedo ECL, editors. Reumatologia pediatrica. Rio De Janeiro: Medsi, 1991: 139-51
52. 52. Feinstein AR, Spagnuolo M, Gill FA. Rebound phenomenon in acute rheumatic fever. I. Incidence and significance. Yale J Biol Med 1961; 33: 259-78
53. 53. Spagnuolo M, Feinstein AR. Rebound phenomenon in acute rheumatic fever. II. Treatment and prevention. Yale J Biol Med 1961; 33: 279-98
54. 54. Combined rheumatic fever study group. A comparison of short-term intensive prednisone and acetylsalicylic acid therapy in the treatment of acute rheumatic fever. N Engl J Med 1965; 272: 63-70
55. 55. Albert DA, Harel L, Karrison T. The treatment of rheumatic carditis: a review and meta-analysis. Medicine 1995; 74: 1-12
56. 56. United Kingdom and United States Joint Report on Rheumatic Heart Disease: the natural history of rheumatic fever and rheumatic heart disease: ten-year report of a cooperative clinical trial of ACTH, cortisone and aspirin. Circulation 1965; 32: 457-76
57. 57. Czoniczer G, Amezcua F, Pelargonio S, et al. Therapy of severe rheumatic carditis : comparison of adrenocortical steroids and aspirin. Circulation 1964; 29: 813-9
58. 58. Stollerman GH. Rheumatic fever. Arch Intern Med 1956; 98: 211-20
59. 59. Timmis HH, Hardy JD, Watson DG, et al. Mitral valve replacement in a child during active rheumatic carditis: successful management of sixteen episodes of ventricular fibrillation. Ann Surg 1966; 164: 1034-40
60. 60. Aron AM, Freeman JM, Carter S, et al. The natural history of Sydenham's chorea. Am J Med 1965; 38: 83-95
61. 61. Swedo SE, Leonard HL, Schapiro MB, et al. Sydenham's chorea: physical and psychological symptoms of St Vitus dance. Pediatrics 1993; 91: 706-13
62. 62. Mivakava M, Ohkubo O, Fuchigami T, et al. Effectiveness of haloperidol in the treatment of chorea minor. Brain Dev 1995; 27: 191-6
63. 63. Ben Hamida M, Hamza F. Sydenham's chorea in Tunisia: a report of 65 cases. Ann Med Intern 1979; 130: 359-64
64. 64. Swedo SE. Sydenham's chorea: a model for childhood autoimmune neuropsychiatric disorders. JAMA 1994; 272: 1788-91
65. 65. Stollerman GH, Lewis AJ, Schulyz I, et al. Relationship of immune response to group A streptococci to the course of acute, chronic and recurrent rheumatic fever. Am J Med 1956; 20 (2): 163-9
66. 66. Taranta A, Klienberg E, Feinstein AR, et al. Rheumatic fever in children and adolescents. A long-term epidemiologic study of subsequent prophylaxis, streptococcal infections, and clinical sequelae. Relation of the rheumatic fever recurrence rate per streptococcal infection to pre-existing clinical features of the patients. Ann Intern Med 1964; 60 Suppl. 5: 58-67
67. 67. Cumming RR. Acute rheumatic fever. Can Med Assoc J 1974; 111: 818-21
68. 68. Spagnuolo M, Kloth H, Taranta A, et al. Natural history of rheumatic aortic regurgitation. Criteria predictive of death, congestive heart failure, and angina in young patients. Circulation 1971; 44: 368-80
69. 69. Reyes VP, Raju S, Wynne J, et al. Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N Engl J Med 1994; 331: 961-7
70. 70. Turi ZG, Reyes VP, Raju S, et al. Percutaneous balloon versus surgical closed commissurotomy for mitral stenosis. Circulation 1991; 83: 1179-85
71. 71. Davis J, Schmidt WC. Benzathine penicillin G: its effectiveness in prevention of streptococcal infections in a heavily exposed population. N Engl J Med 1957; 256 (8): 339-42
72. 72. Haffejee I. Rheumatic fever and rheumatic heart disease: the current status of its immunology, diagnostic criteria, and prophylaxis. Q J Med 1992; 305: 641-58
73. 73. Ayoub EM. Resurgence of rheumatic fever in the United States: the changing picture of a preventable illness. Postgrad Med 1992; 92: 133-6
74. 74. Scaglione F, Demartini G, Arcidiacono MM, et al. Optimum treatment of streptococcal pharyngitis. Drugs 1997; 53: 86-97
75. 75. Clinsburg CM, McCracken GH. A controlled comparative study of penicillin V and cefadroxyl therapy of group A streptococcal tonsillopharyngitis. J Int Med Res 1980; 8: 82-6
76. 76. Stillerman M. Comparison of oral cephalosporins with penicillin therapy for group A streptococcal pharyngitis. Pediatr Infect Dis J 1986; 5: 649-54
77. 77. Petz LD. Immunologic cross-reactivity between penicillins and cephalosporins: a review. J Infect Dis 1978; 137 Suppl.: S74-S79
78. 78. Levine BB. Antigenicity and cross-reactivity of penicillins and cephalosporins. J Infect Dis 1973; 128: S364-S366
79. 79. Saxon A, Hassner A, Swabb EA, et al. Lack of cross-reactivity between aztreonam, a monobactum antibiotic, and penicillin in penicillin allergic subjects. J Infect Dis 1984; 149: 16-22
80. 80. Tanz RR, Poncher JR, Corydon KE, et al. Clindamycin treatment of chronic pharyngeal carriage of group A streptococci. J Pediatr 1991; 8: 119-23
81. 81. Dajani A, Taubert K, Ferricri P, et al. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics 1995; 96: 758-64
82. 82. Lue HC, Wu MH, Wang JK, et al. Long-term outcome of patients with rheumatic fever receiving benzathine penicillin G prophylaxis every three weeks versus every four weeks. J Pediatr 1994; 125 (5): 812-6
83. 83. Padmavati S, Gupta V, Prakash K, et al. Penicillin for rheumatic fever prophylaxis 3-weekly or 4-weekly schedule? J Assoc Physicians India 1987; 35 (11); 753-5
84. 84. Kaplan EL, Berrios S, Speth J, et al. Pharmacokinetics of benzathine penicillin G: serum levels during the 28 days after intramuscular injection of 1,200,000 units. J Pediatr 1989; 115 (1): 146-50
85. 85. Saxena S, Grover A, Singh M, et al. Efficacy of 4-weekly penicillin secondary prophylaxis in acute rheumatic fever/rheumatic heart disease (ARF/RHD). Indian Heart J 1996; 48: 490
86. 86. International Rheumatic Fever Study Group. Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. Lancet 1991; 337: 1308-10
87. 87. Sprunt K, Redman W, Leidy G. Penicillin resistant alpha streptococci in the pharynx of patients given oral penicillin. Pediatrics 1968; 42 (6): 957-68
88. 88. Stollerman GH. Rheumatic fever and streptococcal infection. New York: Grune & Stratton, 1975
89. 89. Berrios X, del Campo E, Guzman B, et al. Discontinuing rheumatic fever prophylaxis in selected adolescents and young adults: a prospective study. Ann Intern Med 1993; 118 (6): 401-6
90. 90. Majeed HA, Khuffash FA, Bhatnagar S, et al. Acute rheumatic polyarthritis: the duration of secondary prophylaxis. Am J Dis Child 1990; 144 (7): 831-3
91. 91. Lancefield RC. Current knowledge of the type specific M antigens of group A streptococci. J Immunol 1962; 89: 307-13
92. 92. Beachy EH, Stollerman GH, Johnson RH, et al. Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein. J Exp Med 1979; 150: 862-77
93. 93. Dale JB, Chiang EY, Lederer JW. Recombinant tetravalent group A streptococcal vaccine. J Immunol 1993; 151: 2188-94